source Post navigation Papillion family believes T1D cure is 'around the corner,' having experienced advancements firsthand – KMTV 3 News Now Omaha Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025 – News-Medical